Atlas Trials

Avastin in Combination With Temozolomide for Unresectable or Multifocal GBMs and Gliosarcomas

Clinical trial NCT00612339 · COMPLETED

Trial details

NCT number
NCT00612339
Sponsor
Duke University
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
GlioblastomaGliosarcoma
Start date
2007-08-01
Primary completion
2012-05-01
Enrollment
41

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.